We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-16.68%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$63B
AUM Growth
-$15.8B
Cap. Flow
-$523M
Cap. Flow %
-0.83%
Top 10 Hldgs %
24.77%
Holding
3,865
New
199
Increased
1,422
Reduced
1,761
Closed
372

Sector Composition

Rank Sector Weight
1 Technology 12.16%
2 Healthcare 9.23%
3 Financials 8.29%
4 Industrials 5.85%
5 Communication Services 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADTN icon
3201
Adtran
ADTN
$658M
$91K ﹤0.01%
11,865
-1,030
-8% -$8.8K
JVA icon
3202
Coffee Holding Co
JVA
$20.2M
$91K ﹤0.01%
38,900
+250
+0.6% +$905
MFGP
3203
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$88K ﹤0.01%
17,272
-269
-2% -$2.73K
NSL
3204
DELISTED
NUVEEN SENIOR INCM FD
NSL
$87K ﹤0.01%
+19,681
New +$108K
CCLP
3205
DELISTED
CSI Compressco LP
CCLP
$86K ﹤0.01%
131,950
-17,325
-12% -$30.1K
CHRD icon
3206
Chord Energy
CHRD
$7.35B
$85K ﹤0.01%
243,539
+65,945
+37% +$121K
GIFI
3207
DELISTED
Gulf Island Fabrication
GIFI
$84K ﹤0.01%
28,065
CVE icon
3208
Cenovus Energy
CVE
$56.4B
$83K ﹤0.01%
41,120
+144
+0.4% +$1.01K
CVU icon
3209
CPI Aerostructures
CVU
$75M
$83K ﹤0.01%
37,100
+700
+2% +$3.16K
KRMD icon
3210
KORU Medical Systems
KRMD
$154M
$83K ﹤0.01%
+11,100
New +$74.7K
VATE icon
3211
INNOVATE Corp
VATE
$102M
$83K ﹤0.01%
5,377
AMPE
3212
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$83K ﹤0.01%
665
+3
+0.5% +$543
GNW icon
3213
Genworth Financial
GNW
$3.77B
$82K ﹤0.01%
24,655
-242,379
-91% -$1.01M
IAG icon
3214
IAMGOLD
IAG
$10.1B
$82K ﹤0.01%
36,250
+5,400
+18% +$15.7K
DRH icon
3215
Diamondrock Hospitality Co
DRH
$2.51B
$81K ﹤0.01%
16,001
+2,240
+16% +$19.3K
SVC
3216
Service Properties Trust
SVC
$1.06B
$81K ﹤0.01%
2,998
-1,464
-33% -$131K
IMMR icon
3217
Immersion
IMMR
$248M
$80K ﹤0.01%
14,925
WBT
3218
DELISTED
Welbilt, Inc.
WBT
$80K ﹤0.01%
15,623
-1,314
-8% -$15.8K
EFC
3219
Ellington Financial
EFC
$1.76B
$78K ﹤0.01%
13,609
+73
+0.5% +$1.14K
JEQ
3220
DELISTED
abrdn Japan Equity Fund
JEQ
$78K ﹤0.01%
12,485
-12,170
-49% -$86.7K
MRC
3221
DELISTED
MRC Global
MRC
$78K ﹤0.01%
18,306
-149
-0.8% -$1.4K
EXD
3222
DELISTED
Eaton Vance TaxManaged Buy-Write Strategy Fund
EXD
$78K ﹤0.01%
+10,196
New +$96K
NBLX
3223
DELISTED
Noble Midstream Partners LP
NBLX
$78K ﹤0.01%
22,219
-27,428
-55% -$459K
ARLP icon
3224
Alliance Resource Partners
ARLP
$3.2B
$77K ﹤0.01%
24,988
-9,001
-26% -$69.3K
ADAM
3225
Adamas Trust
ADAM
$907M
$77K ﹤0.01%
12,342
+3,688
+43% +$77.7K

Similar funds

Raymond James & Associates's Q1 2020 Portfolio in Review

As of Q1 2020, Raymond James & Associates held 3,865 positions worth $63B, down 20% from $78.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q1 2020 filing shows 199 new, 1,422 increased, 1,761 reduced and 372 closed positions. Its largest new stake was BlackRock Health Sciences Trust II: 570,215 shares worth $10.2M. The largest sale was Carnival Corporation Ltd, an estimated $106M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2020 buy was BlackRock Health Sciences Trust II: 570,215 shares worth $10.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2020, an estimated $220M increase.
  • Raymond James & Associates's biggest Q1 2020 reduction was Carnival Corporation Ltd, cutting an estimated $106M.
  • Raymond James & Associates fully exited State Street SPDR Portfolio S&P 400 Mid Cap ETF in Q1 2020, selling an estimated $36.8M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $63B portfolio in Q1 2020.
  • Raymond James & Associates opened 199 new positions and closed 372 in Q1 2020.
  • Raymond James & Associates's portfolio value fell 20% quarter-over-quarter to $63B.

Based on Raymond James & Associates's 13F filing for Q1 2020, filed 21 Apr 2020.